Other clinical trials targeting various cytokines, including IL-6, IL-8, IL-18, IL-1RA, and IL-33, also showed disappointing results without significant clinical effect on MACE, HF hospitalizations, or other cardiovascular outcomes [74]. This evidence concerns the gene IL18 and hydrops fetalis.